Treatment of Chronic Infection with Chlamydia pneumoniae in Asthma

  • P. Black


In recent years evidence has emerged that Chlamydia pneumoniae may have a role in the pathogenesis of asthma. As a result preliminary studies have been conducted on the use of anti-chlamydial antibiotics in subjects with asthma and serological evidence of infection with C. pneumoniae. These studies are discussed below.


Uncontrolled Study Peak Expiratory Flow Rate Macrolide Antibiotic Bronchial Hyperresponsiveness Control Intervention Trial 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Hahn DL, Dodge R, Golubjatnikov R (1991) Association of Chlamydia pneumoniae (strain TWAR) infection with wheezing, asthmatic bronchitis and adult onset asthma. JAMA 266: 225–230PubMedCrossRefGoogle Scholar
  2. 2.
    Hahn DL, Anttila T, Saikku P (1996) Association of Chlamydia pneumoniae IgA antibodies with recently symptomatic asthma. Epidemiol Infect 117: 513–517PubMedCrossRefGoogle Scholar
  3. 3.
    Bjornsson E, Hjelm E, Janson C, Fridell E, Boman G (1996) Serology of Chlamydia in relation to asthma and bronchial hyperresponsiveness. Scand J Infect Dis 28: 63–69PubMedCrossRefGoogle Scholar
  4. 4.
    Cook PJ, Davies P, Tunnicliffe W, Ayres JG, Honeybourne D, Wise R (1998) Chlamydia pneumoniae and asthma. Thorax 53: 254–259PubMedCrossRefGoogle Scholar
  5. 5.
    Kaplan MA, Goldin M (1959) The use of triacetyloleandomycin in chronic infectious asthma. In: Welch H, Marti-Ibauez F (eds) Antibiotic annual 1958–1959. Interscience, New York, pp 273–276Google Scholar
  6. 6.
    Itkin IH, Menzel ML (1970) The use of macrolide antibiotic substances in the treatment of asthma. J Allergy 45: 146–162PubMedCrossRefGoogle Scholar
  7. 7.
    Spector SL, Katz FH, Farr RS (1974) Troleandomycin: effectiveness in steroid-dependent asthma and bronchitis. J Allergy Clin Immunol 54: 367–379CrossRefGoogle Scholar
  8. 8.
    Szefler SJ, Rose JQ, Ellis EF, Spector SL, Green AW, Jusko WJ (1980) The effect of troleandomycin on methylprednisolone elimination. J Allergy Clin Immunol 66: 447–451PubMedCrossRefGoogle Scholar
  9. 9.
    Black PN (1996) The use of macrolides in the treatment of asthma. Eur Respir Rev 6: 240–243Google Scholar
  10. 10.
    Flotte TR, Loughlin GM (1991) Benefits and complications of troleandomycin in young children with steroid-dependent asthma. Pediatr Pulmonol 10: 178–182PubMedCrossRefGoogle Scholar
  11. 11.
    Miyatake H, Taki F, Taniguchi H, Sizuki R, Takagi K, Satake T (1991) Erythromycin reduces the severity of bronchial hyperesponsiveness in asthma. Chest 99: 670–673PubMedCrossRefGoogle Scholar
  12. 12.
    Shimizu T, Kato M, Mochizuki H, Tokuyama K, Morikawa A, Kuroume T (1994) Roxithromycin reduces the degree of bronchial hyperresponsiveness in children with asthma. Chest 106: 458–461PubMedCrossRefGoogle Scholar
  13. 13.
    Kamoi H, Kurihara N, Fujiwara H, Hirata K, Takeda T (1995) The macrolide antibacterial roxithromycin reduces bronchial hyperresponsiveness and Superoxide anion production by polymorphonuclear leukocytes in patients with asthma. J Asthma 32: 151–197CrossRefGoogle Scholar
  14. 14.
    Nelson HS, Hamilos DL, Corsello PR, Levesque NV, Buchmeier Ad, Bucher BL (1993) A double-blind study of troleandomycin and methylprednisolone in asthmatic subjects who require daily corticosteroids. Am Rev Respir Dis 147: 398–404PubMedGoogle Scholar
  15. 15.
    Kamada AK, Hill MR, Ikle DN, Manon Brenner A, Szefler SJ (1993) Efficacy and safety of low-dose troleandomycin therapy in children with severe, steroid-requiring asthma. J Allergy Clin Immunol 91: 873–882PubMedCrossRefGoogle Scholar
  16. 16.
    Hahn DL (1995) Treatment of Chlamydia pneumoniae infection in adult asthma: a before-after trial. J Fam Pract 41: 345–351PubMedGoogle Scholar
  17. 17.
    Emre U, Roblin PM, Gelling M, Dumornay W, Rao M, Hammerschlag MR, Schacter J (1994) The association of Chlamydia pneumoniae infection and reactive airway disease in children. Arch Pediatr Adolesc Med 148: 727–732PubMedCrossRefGoogle Scholar
  18. 18.
    Black PN, Bagg B, Brodie SM, Robinson E, Cooper B (1998) A double-blind, crossover study of roxithromycin in the treatment of asthma. Eur Respir J 12[Suppl 28]: 190s (abstract)Google Scholar
  19. 19.
    Kita E, Sawaki M, Mikasa K, Hamada K, Takeuchi S, Maeda K, Narita N (1993) Alterations of host response by a long term treatment of roxithromycin. J Antimicrob Chemother 32: 285–294PubMedCrossRefGoogle Scholar
  20. 20.
    Juniper EF, Johnston PR, Borkhoff CM, Guyatt GH, Boulet LP, Haukioja A (1995) Quality of life in asthma clinical trials: comparison of salmeterol and salbutamol. Am J Respir Crit Care Med 151: 66–70PubMedGoogle Scholar
  21. 21.
    Hammerschlag MR, Chirgwin K, Roblin PM, Gelling M, Dumornay W, Mandel L, Smith P, Schachter J (1992) Persistent infection with Chlamydia pneumoniae following acute respiratory illness. Clin Infect Dis 14: 178–182PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Italia, Milano 1999

Authors and Affiliations

  • P. Black

There are no affiliations available

Personalised recommendations